Roxanne Lagano Biography and Net Worth

EVP of Zoetis

Roxanne Lagano was appointed executive vice president and chief human resources officer at Zoetis in November 2012. In this role, she is responsible for the company's worldwide human resources management and policies, colleague experience and award-winning workplace.

Ms. Lagano was given responsibility for the Global Operations and Security functions in 2020, and previously had oversight for the company’s Corporate Communications function from 2015-2019.

Prior to joining Zoetis, Ms. Lagano was senior vice president, Global Compensation, Benefits and Wellness for Pfizer. In that role, Ms. Lagano was responsible for the design and implementation of Pfizer's compensation and employee benefit programs around the globe. She was also responsible for Pfizer's wellness strategies, including the Healthy Pfizer program, and for the human resources aspects of the company's merger, acquisition and divestiture activities.

Ms. Lagano joined Pfizer in 1997 as manager, Tax Planning, after specializing in employee benefits, executive compensation and mergers and acquisitions at Schulte, Roth and Zabel, LLP, a New York law firm.

After joining Pfizer's legal division in 1999, Ms. Lagano joined Pfizer's Human Resources organization in 2000. During her time in HR for Pfizer, Ms. Lagano held various positions of increasing responsibility, including senior director of business transactions (HR) and senior director, employee benefits.

Ms. Lagano holds a bachelor’s degree from Long Island University and a Juris Doctor degree from Hofstra University School of Law.

What is Roxanne Lagano's net worth?: The estimated net worth of Roxanne Lagano is at least $2.68 million as of April 18th, 2024. Ms. Lagano owns 14,800 shares of Zoetis stock worth more than $2,682,796 as of October 30th. This net worth approximation does not reflect any other assets that Ms. Lagano may own. Learn More about Roxanne Lagano's net worth.
How old is Roxanne Lagano?: Ms. Lagano is currently 59 years old. There are 7 older executives and no younger executives at Zoetis. Learn More on Roxanne Lagano's age.
How do I contact Roxanne Lagano?: The corporate mailing address for Ms. Lagano and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Roxanne Lagano's contact information.
Has Roxanne Lagano been buying or selling shares of Zoetis?: Roxanne Lagano has not been actively trading shares of Zoetis during the past quarter. Most recently, Roxanne Lagano sold 923 shares of the business's stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $151.17, for a transaction totalling $139,529.91. Following the completion of the sale, the executive vice president now directly owns 14,800 shares of the company's stock, valued at $2,237,316. Learn More on Roxanne Lagano's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 7 times. They sold a total of 19,555 shares worth more than $3,510,698.59. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Roxanne Lagano Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/18/2024	Sell	923	$151.17	$139,529.91	14,800
3/18/2024	Sell	923	$173.33	$159,983.59	15,723
2/12/2024	Sell	363	$197.74	$71,779.62	20,417
1/18/2024	Sell	923	$191.43	$176,689.89	17,569
12/14/2023	Sell	2,500	$200.00	$500,000.00	19,415
11/17/2023	Sell	923	$177.46	$163,795.58	22,665
10/18/2023	Sell	923	$172.92	$159,605.16	23,588
9/18/2023	Sell	923	$179.58	$165,752.34	24,511
9/1/2023	Sell	923	$192.97	$178,111.31	25,434
4/18/2023	Sell	4,338	$175.94	$763,227.72	26,357
7/22/2022	Sell	2,167	$180.26	$390,623.42	23,687
6/27/2022	Sell	4,334	$175.00	$758,450.00	23,687
4/26/2022	Sell	2,167	$178.96	$387,806.32	23,687
2/15/2022	Sell	2,065	$196.54	$405,855.10
12/23/2021	Sell	1,315	$241.70	$317,835.50
11/23/2021	Sell	1,315	$223.09	$293,363.35
10/22/2021	Sell	1,315	$208.03	$273,559.45
9/23/2021	Sell	1,315	$202.17	$265,853.55
8/23/2021	Sell	9,603	$207.07	$1,988,493.21
7/22/2021	Sell	22,450	$199.18	$4,471,591.00
5/19/2021	Sell	6,000	$169.05	$1,014,300.00	53,642
11/19/2020	Sell	6,000	$164.06	$984,360.00	41,680
8/19/2020	Sell	6,000	$160.37	$962,220.00	41,680
5/19/2020	Sell	4,463	$131.02	$584,742.26	40,143
11/19/2019	Sell	4,463	$118.99	$531,052.37	33,190
8/19/2019	Sell	4,463	$125.99	$562,293.37	33,190
5/10/2019	Sell	29,453	$101.65	$2,993,897.45	58,180
4/1/2019	Sell	2,000	$101.89	$203,780.00	30,727
12/31/2018	Sell	2,000	$85.30	$170,600.00
12/31/2018	Sell	2,000	$85.30	$170,600.00	22,023
10/1/2018	Sell	2,000	$92.03	$184,060.00
7/2/2018	Sell	2,000	$84.76	$169,520.00	22,023
2/21/2018	Sell	35,663	$81.02	$2,889,416.26	49,919
11/8/2016	Sell	9,797	$50.43	$494,062.71	8,063

Roxanne Lagano Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $183.25

$179.80

$183.81

50 Day Range

MA: $189.02

$180.01

$196.48

2 Week Range

Now: $183.25

$144.80

$201.92

Volume

536,358 shs

Average Volume

2,501,469 shs

Market Capitalization

$83.02 billion

P/E Ratio

35.86

Dividend Yield

0.96%

Beta

0.89

“Buffett Indicator” Predicts 62% Stock Market Crash

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

Roxanne Lagano Biography and Net Worth

What is Roxanne Lagano's net worth?

How old is Roxanne Lagano?

How do I contact Roxanne Lagano?

Has Roxanne Lagano been buying or selling shares of Zoetis?

Who are Zoetis' active insiders?

Are insiders buying or selling shares of Zoetis?